Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hysterectomy Surgery Safer Than Endometrial Ablation

By HospiMedica International staff writers
Posted on 25 Sep 2019
Laparoscopic supracervical hysterectomy (LASH) for women with heavy menstrual bleeding is as safe as endometrial ablation, but much more effective, claims a new study.

Researchers at the University of Aberdeen (United Kingdom), the University of Glasgow (United Kingdom), Aberdeen Royal Infirmary (United Kingdom), and other institutions conducted a randomized controlled trial in 31 hospitals in Scotland that included 660 women younger than 50 years who were referred to a gynecologist for surgical treatment of heavy menstrual bleeding (menorrhagia), and who were eligible for endometrial ablation.

The patients were randomly allocated to either LASH or second-generation endometrial ablation. More...
The results revealed that 97% of the women allocated to LASH were satisfied with their operation, compared to 87% in the endometrial ablation group. In addition, 69% of the women randomly assigned to LASH were also more likely to have the best possible menorrhagia multi-attribute quality of life scale (MMAS) score (100) than women assigned to endometrial ablation (54%). The study was published on September 12, 2019, in The Lancet.

“This study shows that LASH offers a more effective option than endometrial ablation, without any increased risks,” said lead author consultant gynecologist Professor Kevin Cooper, MD, of the University of Aberdeen. “Most women having this procedure get home within 24 hours and there are no restrictive rules for recovery, unlike traditional hysterectomy. Laparoscopic supracervical hysterectomy offers women another effective surgical choice for this common medical condition.”

Menorrhagia, described as heavy and prolonged menstrual bleeding which disrupts a woman's normal activities, is one of the most common complaints in gynecology. Menorrhagia generally lasts for more than a week, requiring women to change their pad or tampon every two hours or less. In addition, women with menorrhagia may also pass large blood clots and experience anemia due to the volume of blood loss. Constant lower abdominal and pelvic pain, tiredness, fatigue, and shortness of breath due to the heavy bleeding are also common.

Related Links:
University of Aberdeen
University of Glasgow
Aberdeen Royal Infirmary

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.